Shin Nakajima Selected Research

Shin Nakajima Research Topics

3	Neoplasms (Cancer) 09/2020 - 04/2016
3	Glioblastoma (Glioblastoma Multiforme) 08/2018 - 04/2015
3	Glioma (Gliomas) 01/2017 - 10/2014
1	Aneurysm (Aneurysms) 01/2022
1	Reinfection 01/2022
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2022
1	Craniocerebral Trauma (Head Injury) 01/2022
1	Infections 01/2022
1	Pneumocephalus 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	False Aneurysm (Pseudoaneurysm) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Lymphopenia (Lymphocytopenia) 01/2017
1	Lymphoma (Lymphomas) 09/2016
1	Leukoencephalopathies 09/2016
1	Brain Stem Neoplasms (Brain Stem Tumor) 04/2016
1	Intracranial Vasospasm 01/2012
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2012
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2012
1	Rheumatoid Arthritis 04/2011
1	Lipoma (Lipomata) 01/2011
1	Meningomyelocele (Myelomeningocele) 01/2011

2	Biomarkers (Surrogate Marker)IBA 08/2018 - 10/2014
2	Temozolomide (Temodar)FDA LinkGeneric 01/2017 - 04/2015
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	TitaniumIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 09/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2016
1	Bevacizumab (Avastin)FDA Link 04/2015
1	fasudil (AT 877)IBA 01/2012
1	mizoribineIBA 04/2011

4	Radiotherapy 09/2020 - 04/2016
3	Drug Therapy (Chemotherapy) 09/2020 - 04/2015
2	Stents 01/2022 - 01/2022
2	Therapeutics 01/2017 - 04/2015
1	Sutures (Suture) 01/2022
1	Decompression 06/2017
1	Intravenous Injections 01/2017
1	Injections 01/2017
1	Immunotherapy 01/2017
1	Chemoradiotherapy 09/2016
1	Operative Surgical Procedures 01/2011